US$ 21.53
glp 1 and perimenopause Let's talk about GLP-1 medications in the context of menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity GLP-1 receptor agonists | How
Description
The Ozempic Lawsuit is ongoing A new lawsuit has been filed, alleging that Ozempic has caused severe vision loss

Yamada, C

"GLP-1 medications like Ozempic and Wegovy directly alter appetite signaling, gastric emptying and insulin secretion, producing large, predictable effects on weight and blood sugar," Perez explains
Not all patients will qualify for treatment
They are pushing patients and doctors toward the drugs specifically approved for that purpose, like Wegovy and Zepbound, which have their own set of formidable hurdles

The End of the BALANCE Model If you have been following the news, you might remember the BALANCE Model. This was originally supposed to be the way Medicare covered these drugs in 2027, pairing medication access with mandatory lifestyle support programs
